av/odonate-therapeutics--big.svg

NASDAQ:ODT

Odonate Therapeutics, Inc.

  • Stock

USD

Last Close

1.17

01/01 00:00

Volume Today

716.44K

Avg: 959.82K

PE Ratio

−0.29

PFCF: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
net income
-158K
-
-3.08M
1,852.53%
-32.74M
961.39%
-88.96M
171.68%
-111.83M
25.70%
-126.35M
12.99%
depreciation and amortization
20K
-
350K
1,650%
381K
8.86%
445K
16.80%
deferred income tax
stock based compensation
51K
-
3.18M
6,143.14%
6.72M
111.09%
11.44M
70.27%
9.83M
14.12%
change in working capital
-7K
-
2.16M
30,928.57%
193.16M
8,851.11%
-73.84M
138.23%
37.56M
150.86%
-26.35M
170.16%
accounts receivables
inventory
accounts payables
4K
-
529K
13,125%
3.64M
588.47%
6.39M
75.51%
4.78M
25.19%
-1.42M
129.59%
other working capital
-11K
-
1.63M
14,909.09%
189.52M
11,534.32%
-80.23M
142.33%
32.77M
140.85%
-24.93M
176.08%
other non cash items
-857K
-
-189.48M
22,010.04%
88.64M
146.78%
-34.20M
138.58%
29.30M
185.68%
net cash provided by operating activities
-165K
-
-1.73M
950.30%
-25.86M
1,392.09%
-67.09M
159.47%
-96.64M
44.03%
-113.13M
17.07%
investments in property plant and equipment
-83K
-
-1.91M
2,197.59%
-166K
91.30%
-432K
160.24%
acquisitions net
purchases of investments
sales maturities of investments
other investing activites
net cash used for investing activites
-83K
-
-1.91M
2,197.59%
-166K
91.30%
-432K
160.24%
debt repayment
common stock issued
5.02M
-
221.45M
4,313.93%
9.85M
95.55%
135.10M
1,271.81%
87.38M
35.32%
common stock repurchased
-32K
-
dividends paid
-791K
-
other financing activites
349K
-
3.58M
926.07%
2.98M
16.67%
net cash used provided by financing activities
4.19M
-
221.45M
5,180.09%
10.20M
95.40%
138.68M
1,259.98%
90.37M
34.84%
effect of forex changes on cash
net change in cash
-165K
-
2.46M
1,591.52%
195.51M
7,844.17%
-58.80M
130.08%
41.87M
171.21%
-23.20M
155.39%
cash at beginning of period
303K
-
138K
54.46%
2.60M
1,783.33%
198.10M
7,522.35%
139.30M
29.68%
181.17M
30.06%
cash at end of period
138K
-
2.60M
1,783.33%
198.10M
7,522.35%
139.30M
29.68%
181.17M
30.06%
157.98M
12.80%
operating cash flow
-165K
-
-1.73M
950.30%
-25.86M
1,392.09%
-67.09M
159.47%
-96.64M
44.03%
-113.13M
17.07%
capital expenditure
-83K
-
-1.91M
2,197.59%
-166K
91.30%
-432K
160.24%
free cash flow
-165K
-
-1.73M
950.30%
-25.94M
1,396.88%
-69.00M
165.99%
-96.80M
40.29%
-113.56M
17.31%

All numbers in USD (except ratios and percentages)